The administration of MNC-168 MVs significantly suppressed tumor growth, leading to a significant increase in the number of dendritic cells (DCs) and IFN-γ+CD8+ T cells, suggesting the immunomodulatory effects of MNC-168 MVs through STING signaling. This evidence concerns the gene CD8A and neoplasm.